.ANALYSIS HIGHLIGHT.06 August 2024.
A big randomized measured trial with cisgender ladies highlights the obstacles of fidelity to a day-to-day dental preexposure prophylaxis regiment and displays that twice-yearly shot of lenacapavir can easily keep successful HIV deterrence levels over 6 months.